You did this to us Jim Jim Cramer

$RPID up 13% doesn’t seem crazy when you add to the board someone who leads drug commercialization and process/quality improvement for a $220B pharma giant - significant ongoing validation of technology standard following Lonza and Merck astrazeneca.com/our-company/ou…

$SRPT GS hosted a meeting with FDA CBER Director Dr.Vinay Prasad, where they came away with belief Elevidys full appproval is intact...should bode well for DMD community

So Chinternet zombie $SOHU has $1.2B in net cash/equivalents of which >60% is held offshore in the Caymans from the Sogou sale, Changyou is a cash machine, founder owns almost 40%, bought back 1/5 of DSO in recent months, and current cap is *checks notes* $300MM? And there’s

Anyone know Amazon's ROIC when they have to put CAPEX down for 400,000 of these things?

The bald fuck pissing away the cash embedded in your biotech shitco $XBI Eric Schmidt

$BUR I understand that, in order to survive the reconciliation process, the provision must be "Byrd-Rule" compliant. That means the budgetary effect of the provision cannot be merely incidental to the policy. That appears to be the key uncertainty here as 1/